Bulk Vaccine Supply & Procurement Support
Bulk vaccine supply and vaccine procurement support from OctaGenix helps authorised healthcare organisations access human vaccine categories for routine immunisation, travel medicine, outbreak preparedness, occupational exposure, and special-risk vaccination programmes.
OctaGenix Limited supports healthcare systems, government agencies, hospitals, NGOs, procurement bodies and authorised distributors with vaccine sourcing enquiries, documentation requests, product availability checks and procurement timelines, subject to regulatory and commercial availability.
Through our international sourcing network, biofoundries, and healthcare partnerships, we support the procurement and delivery of selected human vaccine categories recognised by global public health authorities, including the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention, which provide information on internationally available vaccine categories, routine immunisation, travel medicine, occupational exposure, and special-risk vaccination programmes.
- Approved product information and labelling
- cGMP-compliant manufacturing and quality control
- Certified by global regulatory bodies including: MHRA, EMA, FDA, PMDA, TGA & CDA-AMC.
- QP details for PV
- Pharmacovigilance and post-market safety system
- Safety data
- MA Holder details
- Full Dossier (if required)
Human Vaccine Supply for Healthcare Systems
OctaGenix can assist authorised healthcare organisations with sourcing and supply enquiries for the following, vaccine-preventable disease categories, subject to regulatory and commercial availability:
Other Products
Request Vaccine Supply Availability
Get in touch with our team to discuss product availability, procurement requirements, and how OctaGenix can support your healthcare supply needs.
Use the table below to browse human vaccine categories OctaGenix can supply, including routine immunisation, travel medicine, outbreak preparedness, occupational exposure, and special-risk vaccine categories. The catalogue includes vaccine-preventable disease categories such as dengue, Hepatitis B and seasonal influenza, including H3N2-related influenza requirements. For current availability, documentation, pricing, and procurement timelines, submit a vaccine supply enquiry.
| VACCINE CATEGORY | DISEASE AREA / INDICATION | AVAILABLE BRANDS OR PRODUCTS |
|---|---|---|
| Adenovirus | Adenovirus types 4 and 7, mainly military/special-risk use | Adenovirus Type 4 and Type 7 Vaccine, Live, Oral — no trade name |
| Anthrax | Anthrax prevention, mainly occupational, military, emergency preparedness | BioThrax, Cyfendus, Live Attenuated Anthrax |
| Chickenpox / Varicella | Varicella-zoster virus primary infection, chickenpox | Varivax, Varilrix, BIO POX, BARYCELA, Provarix, SKY Varicella; combination MMRV: ProQuad, Priorix-Tetra |
| Chikungunya | Chikungunya virus disease | Ixchiq, Vimkunya |
| Cholera | Cholera, Vibrio cholerae | Dukoral, Vaxchora, Shanchol, Euvichol-Plus, Euvichol-S, Hillchol, Cholvax, mORCVAX, OraVacs |
| COVID-19 | SARS-CoV-2 / COVID-19 | Comirnaty, Spikevax, Nuvaxovid, Covovax, Covaxin, CoronaVac, Covilo, Sputnik V, Sputnik Light, Convidecia, ZyCov-D, Bimervax, Kostaive, Corbevax |
| Dengue | Dengue virus serotypes 1–4 | Dengvaxia, Qdenga / TAK-003; WHO MI4A also lists Odenga. Qdenga is authorised in the EU and other markets. |
| Diphtheria | Diphtheria toxoid-containing vaccines, usually in combination | Infanrix, Daptacel, Pediarix, Vaxelis, Pentacel, Kinrix, Quadracel, Boostrix, Adacel, Tenivac, TdVax, Hexaxim, Infanrix hexa, Pentaxim, Tetraxim |
| Ebola | Ebola virus disease, especially Zaire ebolavirus | Ervebo, Zabdeno, Mvabea, Ad5-EBOV |
| Gonorrhoea | Neisseria gonorrhoeaeinfection | No dedicated licensed gonorrhoea vaccine is currently available globally. England uses the MenB vaccine 4CMenB / Bexsero off-label for selected higher-risk groups; UKHSA notes that gonorrhoea prevention is not a licensed indication for 4CMenB. |
| Haemophilus influenzae type b, Hib | Hib invasive disease, meningitis, pneumonia, sepsis | ActHIB, Hiberix, PedvaxHIB, Peda Hib, Euhib, Quimi-Hib, Baby-Hib; combinations include Pentacel, Vaxelis, Pentaxim, Infanrix hexa, Hexaxim |
| Hepatitis A | Hepatitis A virus infection | Havrix, Vaqta, Avaxim, Healive, Havisure, Aimmugen, HAVAX, PrevaHAV; combination HepA/HepB: Twinrix, Bilive |
| Hepatitis B | Hepatitis B virus infection | Engerix-B, Recombivax HB, Heplisav-B, PreHevbrio, Euvax B, Revac-B+, Regevac B, Heberbiovac HB, HepaVax, Gene-HBvax; combination: Twinrix, Pediarix, Vaxelis, Infanrix hexa, Hexaxim |
| Human papillomavirus, HPV | HPV-related cervical, anal, genital and oropharyngeal cancers; genital warts depending on formulation | Gardasil 9, Gardasil, Cervarix, Cecolin, Cervavac, Papilovax, Walrinvax, Cergadex, NusaGard |
| Influenza / Flu | Seasonal influenza and selected pandemic/avian influenza preparedness | Fluad, Fluzone, Fluzone High-Dose, Fluarix, FluLaval, Flucelvax, Flublok, FluMist, Afluria, Vaxigrip, VaxigripTetra, Influvac, Influvac Tetra, Efluelda, Audenz, Arepanrix |
| Japanese encephalitis | Japanese encephalitis virus | Ixiaro, JEEV, Jenvac, IMOJEV, JEVAC, JEBIK V, Encevac, MBJEV |
| Malaria | Plasmodium falciparummalaria in children in endemic settings | Mosquirix / RTS,S/AS01, R21/Matrix-M. WHO recommends RTS,S and R21 for prevention of malaria in children in endemic areas. |
| Measles | Measles virus | M-M-R II, Priorix, Measbio, MVVAC, Mearubik, MRVAC; combination MR/MMR/MMRV: ProQuad, Priorix-Tetra |
| Meningococcal disease / meningitis | Neisseria meningitidisgroups A, B, C, W, Y and X depending on product | Bexsero, Trumenba, Menveo, MenQuadfi, Nimenrix, Menactra, Penbraya, Penmenvy, MenAfriVac, MenFive, NeisVac-C, Menjugate, Meningitec |
| Mpox / Monkeypox | Mpox and, for some products, smallpox preparedness | Jynneos, Imvanex, Imvamune, ACAM2000, LC16 KMB |
| Mumps | Mumps virus | M-M-R II, Priorix, MMR-Pak, Vactrivir, ZyVac MMR; MMRV combinations: ProQuad, Priorix-Tetra |
| Pertussis / Whooping cough | Bordetella pertussis, acellular or whole-cell pertussis combinations | Infanrix, Daptacel, Boostrix, Adacel, Pediarix, Pentacel, Vaxelis, Hexaxim, Infanrix hexa, Pentaxim, Tetraxim, Pertagen, DTwP/DTP products |
| Pneumococcal disease | Streptococcus pneumoniaeinvasive disease, pneumonia, meningitis, otitis media | Prevnar 13 / Prevenar 13, Prevnar 20, Vaxneuvance, Capvaxive, Pneumovax 23, Synflorix, Pneumosil, PNEUBEVAX 14, Prenovax 23 |
| Polio / Poliomyelitis | Poliovirus types 1, 2 and 3; IPV, OPV, bOPV, nOPV depending on programme | IPOL, Imovax Polio, Poliovax, Picovax, Eupolio, IPVAX, bOPV, mOPV1, mOPV2, mOPV3, nOPV2; combination products: Kinrix, Quadracel, Pentacel, Pentaxim, Tetraxim, Infanrix IPV, Hexaxim, Vaxelis |
| Rabies | Rabies virus, pre- and post-exposure prophylaxis | RabAvert / Rabipur, Imovax Rabies, Verorab, Abhayrab, ChiroRab, Indirab, BERAB, VaxiRab N, Speeda |
| Respiratory syncytial virus, RSV | RSV lower respiratory tract disease in older adults, pregnancy/infant protection depending on product | Vaccines: Arexvy, Abrysvo, Mresvia. Passive immunisation products, not vaccines: Beyfortus, Enflonsia, Synagis. FDA lists RSV vaccines and CDC lists RSV monoclonal antibody products separately. |
| Rotavirus | Rotavirus gastroenteritis in infants | Rotarix, RotaTeq, Rotavac, Rotavac 5D, Rotasiil, Rotasiil Thermo, Rotasiil-Liquid, Roatvin |
| Rubella | Rubella virus, including prevention of congenital rubella syndrome | M-M-R II, Priorix, MRVAC, Rubavax-M, Mearubik; MMRV: ProQuad, Priorix-Tetra |
| Shingles / Herpes zoster | Herpes zoster and post-herpetic neuralgia prevention | Shingrix, Zostavax, SKYZoster, live herpes zoster vaccine products |
| Smallpox | Smallpox preparedness; some products also used for mpox | Jynneos, Imvanex, Imvamune, ACAM2000, LC16 KMB |
| Tetanus | Tetanus toxoid-containing vaccines, standalone or combination | Tenivac, TdVax, Boostrix, Adacel, Tetavax, Imovax Tetano, TT, Bio-TT, Tetadif, Td, DT, DTP/DTaP combination products |
| Tick-borne encephalitis | Tick-borne encephalitis virus | Ticovac, Ticovac Junior, Encepur Adult, Encepur Paediatric, EnceVir, EnceVirNeo, Klesch-E-Vac / Leshch-E-Vak |
| Tuberculosis, BCG | Tuberculosis prevention, mainly severe childhood TB | BCG Vaccine SSI, BCG Vaccine AJV, BCG Vaccine I.P., BCG Vaccine, Freeze-dried BCG vaccine, BCG Vaccine for Intradermal Injection |
| Typhoid fever | Salmonella Typhi; Vi polysaccharide, live oral Ty21a, and typhoid conjugate vaccines | Typhim Vi, Vivotif, Typbar-TCV, Typbar, TYPHIBEV, PedaTyph, Typhocon, Bio-TCV, ZyVac TCV, Vianvac |
| Yellow fever | Yellow fever virus | Stamaril, YF-Vax, Yellow Fever Vaccine Live, Stabilized Yellow Fever Vaccine |
FAQ
Frequently Asked Questions About Bulk Vaccine Supply
OctaGenix can support human vaccine categories across routine immunisation, travel medicine, outbreak preparedness, occupational exposure and special-risk vaccination programmes. Examples listed in the vaccine category table include dengue vaccine products such as Qdenga / TAK-003, Hepatitis B vaccine products and seasonal influenza vaccine products, including H3N2-related influenza requirements.
Yes. OctaGenix can support vaccine procurement enquiries, product availability checks, documentation requests, procurement timelines, and supply requirements.
OctaGenix can support human vaccine categories across routine immunisation, travel medicine, outbreak preparedness, occupational exposure, and special-risk vaccination programmes.
Yes. OctaGenix can support documentation requests including approved product information and labelling, cGMP-compliant manufacturing and quality control information, pharmacovigilance details, safety data, MA holder details, QP details for PV, and full dossier support where required.
Visit our Contact Us page and submit a vaccine enquiry with the required vaccine category or product, destination market, estimated quantity, procurement timeline and documentation requirements. The OctaGenix team will review your request and follow up.
